BIOVIE INC. — insider transactions
4 transactions on record · CIK 1580149
Aggregates
computed from the filings belowPurchases, 12m
4
count of open-market buys
Sales, 12m
0
count of open-market sales
Buy / sell ratio, 12m
—
no sales recorded
Distinct insiders, 12m
4
Bought, 3m
$49.1K
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$31.6K
2026-08-27
Director share, 12m
50.0%
of transactions where role is stated
Current run
4 buys
consecutive same-direction transactions
Net 3m flow
$49.1K
purchases minus sales
Total on record
4
Transactions
4 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | 2026-08-28 | 0 | KIM JOANNE WENDY | Chief Financial Officer | Open market purchase | 2,500 | $2.18 | $5.5K | filing |
| 2026-08-28 | 2026-08-27 | 1 | DO CUONG V | Director, CEO | Open market purchase | 15,210 | $2.08 | $31.6K | filing |
| 2026-08-28 | 2026-08-28 | 0 | Chappell Amy Suzon | Director | Open market purchase | 727 | $2.16 | $1.6K | filing |
| 2026-08-28 | 2026-08-28 | 0 | Palumbo Joseph M | Chief Medical Officer | Open market purchase | 4,843 | $2.16 | $10.5K | filing |